CHA sent a comment letter to the FDA on draft guidance that recommends how and when manufacturers provide additional information in drug shortage notifications to the agency. Our letter urges the FDA to address the specific challenges facing the pediatric drug supply chain through transparency requirements, developing proactive shortage mitigation plans, and ensuring an accounting of pediatric drugs on the FDA drug shortages list.
CHA Submits Comments on FDA Drug Shortage Guidance
Related Content
CHA and Children’s Hospitals Urge Support for TRICARE Payment Adjustment
The provision would establish a more appropriate payment adjustment within the TRICARE program for outpatient services provided to children of service members by children’s hospitals.
Children’s Hospital Association Unveils Bold New Brand to Lead the Future of Children’s Health
New mission and identity signal a renewed commitment to unify perspectives, inform decisions, and drive progress.
More Than a New Look: CHA's New Brand Reflects Our Commitment to Children
CHA’s new identity will unify our voice, amplify our impact, and put children’s health at the center of the national conversation.